Association of hydralazine use with risk of hematologic neoplasms in patients with hypertension: A nationwide population-based cohort study in Taiwan.
<h4>Background</h4>Onco-hypertension recognizes well-controlled blood pressure as a favorable prognostic factor for survival in patients with hypertension and solid tumors, including hematologic neoplasms. However, it remains unknown whether continuous use of hydralazine-an antihypertensive agent (A...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Public Library of Science (PLoS)
2025-12-01
|
| Серія: | PLoS Medicine |
| Онлайн доступ: | https://doi.org/10.1371/journal.pmed.1004646 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|